Become a HOPA Annual Conference Presenter
We Have Extended our Call for Annual Conference 2025 Speakers!
HOPA Annual Conference 2025 (HOPA2025) is April 9-12 in Portland, Oregon. The Annual Conference Committee is well on our way to selecting topics and speakers and has one final request for general education sessions.
Speakers Needed for Select HOPA 2025 General Sessions
- Pipelines in Novel Agents for Solid Tumors
- Maintenance Therapy in AML Pre/Post Transplant Therapy
- Pediatrics Clinical Pearls
- Updates In Metastatic HR+ HER2- Breast Cancer- Current Landscape and Future Directions
General Sessions are 60-90 minutes in length and focus on information that may be of interest to a broad audience.
Please submit your topic proposal by September 9, 2024
The Original Call for HOPA 2025 Speakers is Now Closed
The HOPA Annual Conference Committee is seeking speakers for topic areas including solid oncology, hematology, transplantation and cellular therapy, pediatric hematology/oncology, practice management, and much more!
The Call for HOPA 2025 Sessions is Closed
Topics for General HOPA2025 Sessions:
- Classical Hematology
- Innovation in Pharmacy Oncology Services
- Malignant Hematology
- Oncology Operations
- Pediatric Hematology/Oncology
- Practice Management
- Residency topics
- Solid Oncology
- Transplantation & Cellular Therapy
- Other - please describe in your proposal
Topics for AC25 BCOP Sessions:
- Cell Therapy Primer for Solid Tumors (BsAbs, TIL, etc.)
- ctDNA as Tool for Cancer Care From Screening to Treatment
- Navigating Challenging Conversations in Care
- Pharmacogenomics / Genetic Implications of Cancer
- Updates in CLL
- Updates in Hemophilia A & B (Gene Therapy + Non-Factor Therapies)
- Other - please describe in your proposal
Topics for HOPA2025 Breakout Sessions:
- Practical Issue of Clinicians
- Practice Management
- Rare Malignancies
- Special Populations
- Updates in Hematology
- Updates in Solid Tumors
- Other - please describe in your proposal
Call for Speakers Guidelines and Information
All sessions require one learning objective per 15 minutes of content.
- General Sessions
- 60-90 minutes in length and focus on information that may be of interest to a broad audience
- BCOP Sessions
- 60-90 minutes in length; BCOP speakers must be board certified by the Board of Pharmaceutical Specialties (BPS), have clinical experience in the subject, and have national or regional speaking experience
- Breakout Sessions
- 30 minutes in length and may represent more brief updates that are of general interest or topics that might be considered relevant in a given specialty area
- Pre-Conference Workshop
- 3-4 hours in length and provide in-depth coverage on a topic of broad interest